| Literature DB >> 29125237 |
Maryam Hashemian1,2,3, Gwen Murphy2, Arash Etemadi1,2, Hossein Poustchi1,4, John D Brockman5, Farin Kamangar6,7, Akram Pourshams4, Masoud Khoshnia6,8, Abdolsamad Gharavi6,8, Sanford M Dawsey2, Paul J Brennan9, Paolo Boffetta10, Azita Hekmatdoost11, Reza Malekzadeh1,6, Christian C Abnet2.
Abstract
Studies conducted in China linked selenium deficiency to higher risk of esophageal squamous cell carcinoma (ESCC), but this has not been widely tested outside that selenium-deficient region. The aim of this study was to investigate the association between selenium and other mineral concentrations in toenails and risk of ESCC in a region with high incidence rates. In this nested case-control study, we identified 222 cases of ESCC from the Golestan Cohort Study, Iran, which has followed up 50,045 participants since enrollment (2004-2008). We randomly selected one control for each case matched by age and sex, using incidence density sampling. We used toenail samples collected at baseline to measure the concentration of selenium, zinc, chromium, mercury, and scandium using instrumental neutron activation analysis. Multivariate adjusted logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals. Median nail selenium, zinc, chromium, and mercury levels were 1.01, 74.59, 0.77, and 0.018 μg/g in cases and 1.02, 75.71, 0.71, and 0.023 μg/g in controls, respectively. The adjusted odds ratios comparing each fourth quartile of mineral status versus the first quartile were as follows: selenium = 0.78 (95% CI, 0.41-1.49); zinc=0.80 (95% CI, 0.42-1.53); chromium = 0.91 (95% CI, 0.46-1.80); and mercury=0.61 (95% CI, 0.27-1.38), and all trend tests were non-significant. The nail selenium concentration in our controls reflects relatively high selenium status. No evidence of association between selenium or chromium concentrations in toenails and the risk of ESCC was detected in this population.Entities:
Keywords: Chromium; esophageal cancer; mercury; selenium; trace elements; zinc
Mesh:
Substances:
Year: 2017 PMID: 29125237 PMCID: PMC5727321 DOI: 10.1002/cam4.1247
Source DB: PubMed Journal: Cancer Med ISSN: 2045-7634 Impact factor: 4.452
Baseline characteristics of esophageal squamous cell carcinoma case and control participants in the golestan cohort study
| ESCC Case subjects ( | Control subjects ( |
| |
|---|---|---|---|
| Age, years | 60.2 ± 9.3 | 59.1 ± 9.3 | 0.23 |
| Male | 120 (54.3) | 120 (54.1) | 0.96 |
| BMI | 23.1 ± 4.4 | 26.8 ± 6.1 | <0.001 |
| Smoking, pack‐year | 5.7 ± 19.6 | 2.9 ± 9.1 | 0.30 |
| SES | <0.001 | ||
| Low | 106 (48.0) | 60 (27.0) | |
| Low‐ Medium | 54 (24.4) | 55 (24.8) | |
| Medium‐ High | 41 (18.5) | 58 (26.1) | |
| High | 20 (9.0) | 49 (22.1) | |
| Family history, positive | 55 (24.9) | 43 (19.3) | 0.16 |
| Place of residence | <0.001 | ||
| Gonbad urban | 17 (7.7) | 81 (36.5) | |
| Gonbad rural | 97 (43.9) | 71 (32.0) | |
| Kalaleh | 98 (44.3) | 68 (30.6) | |
| Aq Qala | 9 (4.1) | 2 (0.9) | |
| Ethnicity, Turkmen | 182 (82.3) | 167 (75.2) | 0.07 |
| Opium use | 57 (25.8) | 37 (16.7) | 0.02 |
| No formal education | 186 (84.1) | 161 (72.52) | 0.003 |
| Physical activity | 0.03 | ||
| Irregular, nonintense | 154 (69.7) | 126 (56.8) | |
| Regular, nonintense | 48 (21.7) | 65 (29.3) | |
| Irregular or regular, intense | 19 (8.6) | 30 (13.5) | |
| Fruit intake, grams/day | 143.3 ± 168.4 | 168.7 ± 123.0 | <0.001 |
| Vegetable intake, grams/day | 176.5 ± 87.3 | 201.4 ± 101.9 | 0.02 |
| Baseline nail mineral levels ( | |||
| Selenium | 1.009 (0.89–1.13) | 1.020 (0.92–1.14) | 0.18 |
| Zinc | 74.59 (62.60–83.67) | 75.71 (63.71–86.89) | 0.22 |
| Chromium | 0.77 (0.47–1.44) | 0.71 (0.42–1.13) | 0.007 |
| Mercury | 0.018 (0.01–0.03) | 0.023 (0.01–0.05) | 0.002 |
Mean ± SD.
Percent.
Associations of nail mineral concentrations and esophageal squamous cell carcinoma in the Golestan Cohort Study
| Quartile analysis | Continuous analysis | ||||||
|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 |
|
| ||
| Selenium | |||||||
| Cases | 70 | 45 | 54 | 52 | |||
| OR | 1 | 0.65 (0.39–1.11) | 0.77 (0.46–1.29) | 0.76 (0.45–1.27) | 0.38 | 0.94 (0.84–1.06) | 0.35 |
| OR | 1 | 0.90 (0.48–1.69) | 0.92 (0.49 –1.74) | 0.78 (0.41–1.49) | 0.48 | 0.94 (0.80–1.09) | 0.40 |
| Zinc | |||||||
| Cases | 64 | 55 | 55 | 47 | |||
| OR | 1 | 0.87 (0.52–1.47) | 0.86 (0.51–1.44) | 0.75 (0.44–1.27) | 0.29 | 0.92 (0.82–1.03) | 0.13 |
| OR | 1 | 0.75 (041–1.37) | 0.90 (0.49–1.67) | 0.80 (0.42–1.53) | 0.62 | 0.96 (0.83–1.10) | 0.54 |
| Chromium | |||||||
| Cases | 45 | 55 | 50 | 71 | |||
| OR | 1 | 1.24 (0.72–2.14) | 1.11 (0.64–1.92) | 1.61 (0.95–2.72) | 0.09 | 1.1 (1.01–1.20) | 0.04 |
| OR | 1 | 0.88 (0.44–1.76) | 0.63 (0.31–1.25) | 0.91 (0.46–1.80) | 0.97 | 1.03 (0.93–1.13) | 0.60 |
| Mercury | |||||||
| Cases | 69 | 63 | 66 | 23 | |||
| OR | 1 | 0.93 (0.56–1.54) | 0.97 (0.59–1.61) | 0.33 (0.18–0.61) | <0.001 | 0.84 (0.77–0.92) | 0.000 |
| OR | 1 | 0.95 (0.53–1.70) | 1.59 (0.87–2.91) | 0.61 (0.27–1.38) | 0.29 | 0.88 (0.79–0.99) | 0.03 |
should be interpreted as increase of 0.11 μg/g for selenium, 11.15 μg/g for zinc, 0.40 μg/g for chromium, and 0.01 μg/g for mercury.
Crude model.
Adjusted for age (years), sex (M, F), place of residence (Gonbad urban, Gonbad rural, Kalaleh, Aq Qala), smoking (pack‐years), socioeconomic status (low, low‐medium, medium‐high, high), ethnicity (non‐Turkmen, Turkmen), opiate use (never, ever), body mass index (<18.5, 18.5 to <25, 25 to <30, >=30), education (no formal, formal education), physical activity (irregular nonintense, regular nonintense, irregular or regular intense), family history (positive, negative), fruit intake (g/d), and vegetable intake (g/d); ORs (95% CI) were calculated using an unconditional logistic regression models.
Selenium concentrations of toenail samples among controls in previous studies
| The place of the Study | The name of the Study | Median nail selenium concentrations ( | Mean nail selenium concentrations ( |
|---|---|---|---|
| Iran (current study) | GCS | 1.02 (0.92–1.14) | |
| US, MD [ | CLUE II | 0.79 (0.70–0.87) | |
| US [ | HPFS | 0.80 (0.73–0.94) | |
| Netherlands [ | NLCS | 0.55 (0.48–0.60) | |
| US [ | SELECT | 0.88 (0.77–0.99) | |
| Italy [ | ORDET | 0.96 | |
| China [ | 0.47 (range=008–4.22) | ||
| Finland [ | 0.47 ± 0.09 |
GCS = Golestan Cohort Study.
CLUE II = Campaign against Cancer and Stroke.
HPFS = Health Professionals Follow‐up Study.
NLCS = Netherlands Cohort Study.
SELECT = Selenium and Vitamin E Cancer Prevention Trial.
Hormones and Diet in the Etiology of Breast Cancer.